BC2-28940-02415

4 vaccinations 5 coded responses 26 check-ins 4 free-text entries 4 call cases

Sex: Female
Age at first dose: 31-35
ZIP prefix: 921 / CA
Registered: 2021-02-02

Relationship: Self
Race: Multiracial
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-31
Dose 1 — Pfizer-BioNTech
2021-02-02
Registered in v-safe
2021-02-02
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-02-03
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-02-04
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache, Fatigue or tiredness, Nausea

Adult check-in
2021-02-05
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-02-06
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-02-07
Health check-in — day 7, dose 1
Feeling: Fair · Headache, Fatigue or tiredness

Adult check-in
2021-02-14
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-02-21
Dose 2 — Pfizer-BioNTech
2021-02-22
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Joint pains, Muscle or body aches

Adult check-in
2021-02-23
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea

Adult check-in
2021-02-24
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-02-26
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-03-01
Health check-in — day 7, dose 2
Feeling: Good · Headache

Adult check-in
2021-03-09
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-03-14
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-03-22
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-03-28
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-04-04
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-05-25
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-11-01
Dose 3 — Pfizer-BioNTech
2022-02-21
Survey response — 12 months, dose 2
MedDRA: Pregnancy — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Pregnant (7 weeks)

MedDRA releases: 2024-11 · check-in free text available
2022-02-21
Report sent to call center — 12 months, dose 2
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-02-23
Call 1 — Left Voicemail
2022-05-04
Survey response — 6 months, dose 3
MedDRA: Abortion spontaneous, Haemorrhage — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

Free text: Missed miscarriage, excessive bleeding

MedDRA releases: 2024-11 · check-in free text available
2022-05-04
Report sent to call center — 6 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Emergency room or emergency department visit · 1 call case(s)
2022-05-05
Call 1 — Could Not Reach Participant
2022-05-10
Call 2 — Left Voicemail
2022-10-14
Dose 4 — Moderna
2022-11-04
Survey response — 12 months, dose 3
MedDRA: Abortion spontaneous, Anaemia, Iron deficiency, Uterine dilation and curettage, Uterine haemorrhage, Von Willebrand's disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization

Free text: Likely Von Willebrand disease type 1. Excessive bleeding after a miscarriage and dilation and curettage, resulting in a second D&C, iron deficiency, and iron infusion.

MedDRA releases: 2024-11 · check-in free text available
2022-11-04
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2022-11-06
Health check-in — day 21, dose 4
Feeling: Fair

Adult check-in
2022-11-07
Call 2 — Left Voicemail
2022-11-07
Call 3 — Left Voicemail
2022-11-07
Call 1 — Left Voicemail
2022-11-11
Health check-in — day 28, dose 4
Feeling: Good

Adult check-in
2022-11-20
Health check-in — day 35, dose 4
Feeling: Fair

Adult check-in
2022-11-28
Survey response — day 42, dose 4
MedDRA: Cough, Headache, Pain, Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Cough, congestion, runny nose, body aches, headache. COVID test negative.

MedDRA releases: 2024-11 · check-in free text available
2023-01-13
Survey response — 3 months, dose 4
MedDRA: Bronchitis, COVID-19, Influenza — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

MedDRA releases: 2024-11
2023-01-13
Report sent to call center — 3 months, dose 4
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2023-01-17
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-31	Pfizer-BioNTech
2	2021-02-21	Pfizer-BioNTech
3	2021-11-01	Pfizer-BioNTech	No
4	2022-10-14	Moderna	No

Call center

Reported	Outcome	VAERS-related outcome
2022-02-21	Unsuccessful
2022-05-04	Unsuccessful
2022-11-04	Unsuccessful
2023-01-13	Unsuccessful

Free text

Release 11 — 12 months, dose 2

2022-02-21

Symptoms: Pregnant (7 weeks)

Release 11 — 6 months, dose 3

2022-05-04

Symptoms: Missed miscarriage, excessive bleeding

Release 12 — 12 months, dose 3

2022-11-04

Symptoms: Likely Von Willebrand disease type 1. Excessive bleeding after a miscarriage and dilation and curettage, resulting in a second D&C, iron deficiency, and iron infusion.

Release 12 — day 42, dose 4

2022-11-28

Symptoms: Cough, congestion, runny nose, body aches, headache. COVID test negative.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Abortion spontaneous	·	·	✓
SD	Anaemia	·	·	✓
SD	Bronchitis	·	·	✓
SD	Cough	·	·	✓
SD	COVID-19	·	·	✓
SD	Haemorrhage	·	·	✓
SD	Headache	·	·	✓
SD	Influenza	·	·	✓
SD	Iron deficiency	·	·	✓
SD	Pain	·	·	✓
SD	Pregnancy	·	·	✓
SD	Respiratory tract congestion	·	·	✓
SD	Rhinorrhoea	·	·	✓
SD	SARS-CoV-2 test negative	·	·	✓
SD	Uterine dilation and curettage	·	·	✓
SD	Uterine haemorrhage	·	·	✓
SD	Von Willebrand's disease	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release